Reply to Aljabali et al. Comment on "Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213".

Saved in:
Bibliographic Details
Title: Reply to Aljabali et al. Comment on "Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213".
Authors: Abdelazeem B; Department of Medicine, McLaren Health Care, Flint, MI 48532, USA.; Department of Medicine, Michigan State University, East Lansing, MI 48532, USA., Abbas KS; Faculty of Medicine, Alexandria University, Alexandria 22621, Egypt., Brašić JR; Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2022 Jun 13; Vol. 58 (6). Date of Electronic Publication: 2022 Jun 13.
Publication Type: Journal Article; Meta-Analysis; Systematic Review
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1648-9144
DOI:10.3390/medicina58060793